Pourtau, L., Wauquier, F., Boutin-Wittrant, L., Gaudout, D., Moras, B., Vignault, A., . . . Wittrant, Y. (2024). Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake. Pharmaceutics, 16(3), 336. https://doi.org/10.3390/pharmaceutics16030336
Chicago Style (17th ed.) CitationPourtau, Line, et al. "Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake." Pharmaceutics 16, no. 3 (2024): 336. https://doi.org/10.3390/pharmaceutics16030336.
MLA (9th ed.) CitationPourtau, Line, et al. "Reduced Production of Pro-Inflammatory and Pro-Catabolic Factors by Human Serum Metabolites Derived from a Patented Saffron Extract Intake." Pharmaceutics, vol. 16, no. 3, 2024, p. 336, https://doi.org/10.3390/pharmaceutics16030336.